These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37129114)

  • 1. Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Hardy KK; Kairalla JA; Gioia AR; Weisman HS; Gurung M; Noll RB; Hinds PS; Hibbitts E; Salzer WL; Burke MJ; Winick NJ; Embry L
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30350. PubMed ID: 37129114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia.
    Cole PD; Kim SY; Li Y; Schembri A; Kelly KM; Sulis ML; Vrooman L; Welch JJG; Ramjan S; Silverman LB; Sands SA
    Support Care Cancer; 2023 Jan; 31(2):109. PubMed ID: 36625831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG).
    Hardy KK; Embry L; Kairalla JA; Sharkey C; Gioia AR; Griffin D; Berger C; Weisman HS; Noll RB; Winick NJ
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31179. PubMed ID: 39175358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
    Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
    Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserved executive functioning and low stress symptoms in children treated for acute lymphoblastic leukemia.
    Godoy PBG; Mello CB; Pompéia S; da Costa CML; Cypriano MDS; Suchecki D
    Appl Neuropsychol Child; 2022; 11(3):270-279. PubMed ID: 32787697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Working memory training in survivors of pediatric cancer: a randomized pilot study.
    Hardy KK; Willard VW; Allen TM; Bonner MJ
    Psychooncology; 2013 Aug; 22(8):1856-65. PubMed ID: 23203754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
    Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
    Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy.
    Egset KS; Stubberud J; Ruud E; Hjort MA; Eilertsen MB; Sund AM; Hjemdal O; Weider S; Reinfjell T
    J Int Neuropsychol Soc; 2024 Jul; 30(6):523-532. PubMed ID: 38465668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.
    Walsh KS; Paltin I; Gioia GA; Isquith P; Kadan-Lottick NS; Neglia JP; Brouwers P
    Child Neuropsychol; 2015; 21(1):78-89. PubMed ID: 24428397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
    Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
    Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Trajectories of Neurocognitive Functioning in Childhood Acute Lymphoblastic Leukemia.
    Partanen M; Phipps S; Russell K; Anghelescu DL; Wolf J; Conklin HM; Krull KR; Inaba H; Pui CH; Jacola LM
    J Pediatr Psychol; 2021 Feb; 46(2):168-178. PubMed ID: 33011782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia.
    van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ
    Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
    Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
    J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.